Undisclosed financial COI [US psychiatry]
This BMJ research is open access and can be read in full here.
Tag: Pharmaceutical industry
Drug industry payments to groups of influential MPs – “the next great parliamentary scandal?”
I have submitted the following rapid response to the BMJ News article: Drug industry payments to groups of influential MPs – “the next great parliamentary scandal?” I am in agreement … Continue reading Drug industry payments to groups of influential MPs – “the next great parliamentary scandal?”
The potential and limits of scrutiny in medical research
I have submitted the following rapid response to the BMJ Editorial: The potential and limits of scrutiny in medical research: Thank you editor for welcoming ideas on this important matter. … Continue reading The potential and limits of scrutiny in medical research
Déjà vu
The recent publication in JAMA Psychiatry: Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis made me feel that I had been here before. Once again, a … Continue reading Déjà vu
“Drug development in psychiatry: 50 years of failure and how to resuscitate it”
This opinion by Professor David Nutt was published in Lancet Psychiatry, 11 February 2025: Table 1: Table 2:
Should biomarkers [and Pharma] drive Alzheimer’s diagnosis?
This news item by Alicia Ault was published in Medscape, 27 January 2025:
My Question to the MHRA
On the 22nd October 2024, at the invite of Lord David Alton, I attended a meeting held in the House of Lords. This meeting was to consider safety warnings in … Continue reading My Question to the MHRA
The Political Sociology of NICE
An open access paper, published November 2024